Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6707-6715
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6707
Table 1 Hepatic flares in patients with hepatitis C virus chronic infection: Main characteristics of published studies
Ref.Type of studyPatients (flare/total)Patients with flareEtiology of flare
Sheen et al[39]Prospective78/19440%Spontaneous ae-CHC
Tsuji et al[47]Prospective28/12023.30%Spontaneous ae-CHC
Rumi et al[41]Prospective39/20619%Spontaneous ae-CHC
Ferri et al[64]Prospective1/313.20%ae-CHC due to anti-TNF alfa
Pitini et al[53]Prospective10/10/ae-CHC due to anti-CD20
Coppola et al[50]Prospective longitudinal7/7/ae-CHC due to anti-CD20
Grebely et al[85]Prospective5/1363%HCV-superinfection
Sagnelli et al[43]Cross-sectional82/82/Spontaneous ae-CHC
Coppola et al[48]Cross-sectional57/57/Spontaneous ae-CHC
Sagnelli et al[67]Cross-sectional8/8/HAV superinfection
Biliotti et al[80]Cross-sectional14/14/HBV superinfection
Sagnelli et al[81]Cross-sectional29/29/HBV superinfection
Pritchard[65]Case report1/1/ae-CHC due to anti-TNF alfa
Deterding et al[84]Case report1/17%HBV/HDV superinfection
Sagnelli et al[86]Case report1/1/HCV-superinfection
Accapezzato et al[90]Case report1/1/HCV-superinfection
Hiraga et al[40]Retrospective22/17601.25%Spontaneous ae-CHC
Ennishi et al[51]Retrospective36/13127.40%ae-CHC due to anti-CD20
Mahale et al[62]Retrospective33/30811%ae-CHC related to chemotherapy
Li et al[66]Retrospective1/812.50%ae-CHC due to anti-TNF alfa
Marignani et al[52]Retrospective2/366.60%ae-CHC due to anti-CD20